Inessa Gendlina

21 papers receiving 495 citations

Peers

Inessa Gendlina
Comparison fields: 5 of 89
  • Infectious Diseases 233
  • Applied Microbiology and Biotechnology 156
  • Epidemiology 146
  • Molecular Biology 73
  • Critical Care and Intensive Care Medicine 65
Replace Nikolaos Spernovasilis with:
Nikolaos Spernovasilis Greece
Sandra Valderrama Colombia
Teresa Sukiennik Brazil
Ruwandi Kariyawasam Canada
Bibhabati Mishra India
Andrea Bedini Italy
Ernestina Repetto Belgium
Dawn Terashita United States
Chenchao Fu China
Todd J. Vento United States
Inessa Gendlina relative to Nikolaos Spernovasilis Greece Nikolaos Spernovasilis's profile →
Citations per field
00.5×1.5×2.5×
Nikolaos Spernovasilis · 1×
Citations per year

Countries citing papers authored by Inessa Gendlina

Since Specialization
Citations

This map shows the geographic impact of Inessa Gendlina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inessa Gendlina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inessa Gendlina more than expected).

Fields of papers citing papers by Inessa Gendlina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inessa Gendlina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inessa Gendlina. The network helps show where Inessa Gendlina may publish in the future.

Co-authorship network of co-authors of Inessa Gendlina

This figure shows the co-authorship network connecting the top 25 collaborators of Inessa Gendlina. A scholar is included among the top collaborators of Inessa Gendlina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inessa Gendlina. Inessa Gendlina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 12
4 5
5 0
6 8
7 1
8 2
9 25
10 4
11 203
12 4
13 30
14 22
15 21
16 72
17 9
18 37
19 12
20 28

About Inessa Gendlina

Inessa Gendlina is a scholar working on Applied Microbiology and Biotechnology, Family Practice and Critical Care and Intensive Care Medicine, having authored 24 papers that have together received 507 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (4 papers), Antibiotic Use and Resistance (3 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (156 citations), Infectious Diseases (233 citations) and Critical Care and Intensive Care Medicine (65 citations). Inessa Gendlina has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Theresa Madaline, Priya Nori, Joshua D. Nosanchuk, Yi Guo, Wendy Szymczak, Philip Gialanella, Kelsie Cowman, Rachel Bartash, Gregory Weston and Margaret Aldrich. Their work appears in journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026